Product Reports Resources Pricing Login Book a demo

CF PharmTech

Biotech & Life Sciences · Suzhou Shi, China · Founded 2007 · IPO 2025

Specialty pharmaceutical company that develops and manufactures inhalation products MoreLess

PharmTech USA Inc., located in the City of Industry, California, is a dynamic startup specializing in the development and manufacturing of advanced drug delivery systems. The company focuses on creating innovative inhalation products, such as nasal powder inhalers and nebulized sprays. These products are designed to deliver medication directly to the respiratory system, offering a more efficient and effective treatment for patients with respiratory conditions.

PharmTech serves a diverse range of clients, including pharmaceutical companies, healthcare providers, and patients who require specialized inhalation therapies. The company operates in the pharmaceutical and healthcare market, which is a rapidly growing sector driven by the increasing prevalence of respiratory diseases and the demand for more effective drug delivery methods.

The business model of PharmTech revolves around research and development (R&D), manufacturing, and distribution. The company invests heavily in R&D to create cutting-edge inhalation products that meet the highest standards of safety and efficacy. Once developed, these products are manufactured in their state-of-the-art facilities and distributed to clients through various channels, including direct sales and partnerships with pharmaceutical companies.

PharmTech generates revenue primarily through the sale of its inhalation products. Additionally, the company may engage in licensing agreements and partnerships with other pharmaceutical firms, allowing them to leverage PharmTech's technology and expertise in drug delivery systems. This diversified revenue stream helps the company maintain financial stability and support ongoing innovation.

In summary, PharmTech USA Inc. is a forward-thinking company dedicated to improving respiratory health through advanced inhalation products. By focusing on R&D, manufacturing, and strategic partnerships, the company is well-positioned to capitalize on the growing demand for effective drug delivery solutions.

Keywords: inhalation products, nasal powder inhalers, nebulized sprays, respiratory health, drug delivery systems, pharmaceutical, healthcare, R&D, manufacturing, partnerships.

Valuation $811M
Revenue $59M
EBITDA $8.2M
Total funding $100–500M

Talent graph

CF PharmTech's talent

Book a demo to see the people
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

14 investors on CF PharmTech's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 14 investors entered at this stage
SDIC Fund Management
New Alliance Capital
ShenZhen GTJA Investment Group
CR-CP Life Science Fund
Xiangcheng Financial Holdings
Cornerstone Capital
Oriza Holdings
GT Capital
China Capital Investment Group
BioTrack Capital
Passion Capital
YuanMing Capital
SAIC Capital
Hengxu Capital

Global footprint

Where CF PharmTech has talent and traffic

Workforce by country
2 countries with
team presence
🇨🇳 China94.1%
🇺🇸 United States5.9%
2 countries shown
Web traffic by country
1.2K monthly visits
across markets
🇺🇸 United States100%
Top 1 markets shown

Market sentiment

What the market is saying about CF PharmTech

An AI-synthesized read of the highest-engagement posts about CF PharmTech on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CF PharmTech on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.